H. Kolesnikov Gauthier
H. Kolesnikov Gauthier publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Ovarian cancer diagnosis and treatment, Sarcoma Diagnosis and Treatment and Bladder and Urothelial Cancer Treatments.
- World rank
- #3,771,083 of 7,710,434 ranked researchers
- Rank in France
- #158,832 of 324,115
- Works
- 62
- Citations
- 765
- Citations per work
- 12.3
What does H. Kolesnikov Gauthier research?
H. Kolesnikov Gauthier's work is mostly in Medicine (41%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3758.9%
- Health Sciences2541.1%
- Medicine2541.1%
- 1Pulmonary and Respiratory Medicine10% of their works
- 2Surgery10% of their works
- 3Oncology6% of their works
- 4Reproductive Medicine5% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Obstetrics and Gynecology4% of their works
Research topics
- Ovarian cancer diagnosis and treatment
- Sarcoma Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Endometrial and Cervical Cancer Treatments
- Cancer Immunotherapy and Biomarkers
- Renal cell carcinoma treatment
- Urinary and Genital Oncology Studies
- Adsorption, diffusion, and thermodynamic properties of materials
Which keywords describe H. Kolesnikov Gauthier's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Molecular Characterization, Prognostic Factors, Genomic Analysis, Ovarian Cancer and Bladder Cancer.
- Surface Characterization
- Renal Cell Carcinoma
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Cervical Cancer
- Soft Tissue Sarcoma
- Bladder Cancer
- Genomic Analysis
- Molecular Characterization
- Clinical Practice Guidelines
- Chemotherapy
- Immunotherapy
- Prognostic Factors
- Ovarian Cancer
- Osteosarcoma
- Urothelial Carcinoma
- Endometrial Carcinoma
- Metastatic
- Primary Urethral Carcinoma
- Urachal Carcinoma
- Thermodynamic Parameters
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy163 topics
- Clinical Practice Guidelines92 topics
- Immunotherapy92 topics
- Molecular Characterization92 topics
- Prognostic Factors92 topics
- Genomic Analysis61 topic
- Ovarian Cancer61 topic
- Bladder Cancer51 topic
- Osteosarcoma51 topic
- Soft Tissue Sarcoma51 topic
- Urothelial Carcinoma51 topic
- Cervical Cancer41 topic
- Endometrial Carcinoma41 topic
- Immune Checkpoint Blockade41 topic
- Metastatic41 topic
- PD-1 and PD-L141 topic
- Primary Urethral Carcinoma41 topic
- Renal Cell Carcinoma41 topic
- Urachal Carcinoma41 topic
- Surface Characterization31 topic
- Thermodynamic Parameters31 topic
Where does H. Kolesnikov Gauthier work?
H. Kolesnikov Gauthier's main affiliation in the publication record is Centre Oscar Lambret, France.
How many publications and citations does H. Kolesnikov Gauthier have?
OpenAlex counts 62 works and 765 citations for H. Kolesnikov Gauthier, an h-index of 11, ranking #3,771,083 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about H. Kolesnikov Gauthier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.